Skip to main content
eScholarship
Open Access Publications from the University of California

Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing.

  • Author(s): Rouet, Romain
  • Thuma, Benjamin A
  • Roy, Marc D
  • Lintner, Nathanael G
  • Rubitski, David M
  • Finley, James E
  • Wisniewska, Hanna M
  • Mendonsa, Rima
  • Hirsh, Ariana
  • de Oñate, Lorena
  • Compte Barrón, Joan
  • McLellan, Thomas J
  • Bellenger, Justin
  • Feng, Xidong
  • Varghese, Alison
  • Chrunyk, Boris A
  • Borzilleri, Kris
  • Hesp, Kevin D
  • Zhou, Kaihong
  • Ma, Nannan
  • Tu, Meihua
  • Dullea, Robert
  • McClure, Kim F
  • Wilson, Ross C
  • Liras, Spiros
  • Mascitti, Vincent
  • Doudna, Jennifer A
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002863/
No data is associated with this publication.
Abstract

CRISPR-Cas RNA-guided endonucleases hold great promise for disrupting or correcting genomic sequences through site-specific DNA cleavage and repair. However, the lack of methods for cell- and tissue-selective delivery currently limits both research and clinical uses of these enzymes. We report the design and in vitro evaluation of S. pyogenes Cas9 proteins harboring asialoglycoprotein receptor ligands (ASGPrL). In particular, we demonstrate that the resulting ribonucleoproteins (Cas9-ASGPrL RNP) can be engineered to be preferentially internalized into cells expressing the corresponding receptor on their surface. Uptake of such fluorescently labeled proteins in liver-derived cell lines HEPG2 (ASGPr+) and SKHEP (control; diminished ASGPr) was studied by live cell imaging and demonstrates increased accumulation of Cas9-ASGPrL RNP in HEPG2 cells as a result of effective ASGPr-mediated endocytosis. When uptake occurred in the presence of a peptide with endosomolytic properties, we observed receptor-facilitated and cell-type specific gene editing that did not rely on electroporation or the use of transfection reagents. Overall, these in vitro results validate the receptor-mediated delivery of genome-editing enzymes as an approach for cell-selective gene editing and provide a framework for future potential applications to hepatoselective gene editing in vivo.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item